Health Care/Hospital

ATrack's UVengers UV1 verified by Chang Gung University to kill 99.8% of SARS-CoV-2 in 3 seconds

TAIPEI, Sept. 4, 2020 /PRNewswire/ -- ATrack Technology Inc. (TPEX: 6465), an Internet of Vehicles (IoV) company, has established the new brand UVengers that provides disease prevention products to help people stay safe from pathogen-related illnesses during the current pandemic and in the post-p...

2020-09-04 08:00 4851

ezyVet and Openpay enter strategic partnership to extend payment plans to fur babies

AUCKLAND, New Zealand, Sept. 4, 2020 /PRNewswire/ -- Thanks to a new partnership between 'Buy Now Pay Later' (BNPL) payment providerOpenpay (ASX: OPY), and veterinary software provider ezyVet , pet owners can now spread the cost of their vet ...

2020-09-04 07:17 4137

American Neurological Association Hosts First-Ever All-Virtual Annual Meeting

MOUNT LAUREL, New Jersey, Sept. 4 2020 /PRNewswire/ -- On October 4-9, 2020, the American Neurological Association, for the first time in its 145-year history, is moving from a traditional meeting format to an interactive, virtual meeting experience. As always, the meeting will explore the latest...

2020-09-04 02:38 3128

Infosys to Acquire Product Design and Development firm, Kaleidoscope Innovation

Expands engineering services portfolio by strengthening presence in Medical devices, Consumer and Industrial markets across US BENGALURU, India and CINCINNATI, Sept. 4, 2020 /PRNewswire/ -- Infosys  (NYSE: INFY), a global leader in next-generation digital services and c...

2020-09-04 02:36 28155

Alphamab Oncology announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to KN046 for the treatment of thymic epithelial tumor

SUZHOU, China, Sept. 3, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to KN046, a recombinant humanized PD-L1/CTLA-4 bispecific antibody developed by Jiangsu Alphamab Biopharmaceuti...

2020-09-03 23:46 2077

As More Seniors Look to Age Independently, TCL Unveils the MOVETIME Family Watch to Help Keep Seniors Connected

BERLIN, Sept. 3, 2020 /PRNewswire/ -- TCL, one of the world's best-selling consumer electronics brands and leading technology companies, is introducing the MOVETIME Family Watch MT43A today. This 4G connected watch provides hands-free two way calling, automatic fall detection, heart rate monitori...

2020-09-03 21:15 10612

Merck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis

Not intended for UK and US based media - Company to present 54 abstracts across its MS portfolio - MAVENCLAD® (cladribine tablets), Rebif® (interferon beta-1a) and investigational evobrutinib - New long-term data and real-world evidence further characterise efficacy and safety of MAVENCLAD® -...

2020-09-03 20:00 3420

Taking the Pulse® 2020 Physician Survey Shows 4 in 5 U.S. Physicians Have Conducted Virtual Patient Consults Amid the COVID-19 Pandemic

New physician data from Decision Resources Group, part of Clarivate, shows pandemic mitigation measures are shifting how physicians provide care to their patients and stay informed of latest drug developments LONDON, Sept. 3, 2020 /PRNewswire/ -- Decision Resources Group (DRG), part of Clarivate...

2020-09-03 20:00 12071

Innovent Announces NMPA Granted Marketing Approval for SULINNO® (Adalimumab Injection) in China

SAN FRANCISCO, U.S. and SUZHOU, China, Sept. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major ...

2020-09-03 17:50 4489

New investors Thiel and Novogratz introduced to Bionomics by Apeiron Investment Group as part of successful second placement capital raising

SYDNEY, Sept. 3, 2020 /PRNewswire/ -- Following overwhelming shareholder approval, the scheduled second placement of 54,333,000 new shares by Bionomics is proceeding and expected to complete shortly. In accordance with the Subscription Agreement between Apeiron and Bionomics, Apeiron has introduc...

2020-09-03 16:34 23052

Amorepacific Publishes Research Paper On Clinical Evaluation Method For Blue Light 456nm Protection Of Skin

SEOUL, South Korea, Sept. 3, 2020 /PRNewswire/ -- The Anti-Pollution Research Center of Amorepacific R&D Center has developed the world's first clinical evaluation method for blocking blue light from reaching the skin. The research paper, which involves research on the harmful effects of blue lig...

2020-09-03 15:12 3905

Nippon Express Completes Acquisition of Equity Interests in MD Logistics and MD Express (Turning into Subsidiary)

TOKYO, Sept. 3, 2020 /PRNewswire/ -- Nippon Express Co., Ltd. (Code No.9062, First Section, Tokyo Stock Exchange; hereinafter the "Company") hereby announces that, as announced onMay 22, 2020, in the "Acquisition of Equity Interests in MD Logistics, Inc. and MD Express, Inc. (Turning into a Subs...

2020-09-03 15:00 9724

New study demonstrates PICO™ Single Use Negative Pressure Wound Therapy System (sNPWT) beats standard dressings in reducing surgical site complications resulting in fewer deep sternal wound infections (DSWI) following cardiac surgery

LONDON, Sept. 3, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces the publication of a new study in cardiac surgery showing that PICO sNPWT significantly reduced the incidence of surgical site complications (SSCs) by 64%,* which resulted in a...

2020-09-03 15:00 9824

Leading Cancer Treatment Recommendations from NCCN Now Available in French, German, Italian, Portuguese, Russian, and Spanish

Gold standard clinical practice guidelines in oncology translated for greater global accessibility; free online atNCCN.org/global. PLYMOUTH MEETING, Pennsylvania, Sept. 3, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the availability of multiple non-Eng...

2020-09-03 08:45 2272

Up-to-Date Leading Cancer Treatment Recommendations from NCCN Now Available in Chinese

PLYMOUTH MEETING, Pennsylvania, Sept. 3, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the availability of both new and updated Chinese language versions ofNCCN Guidelines® for numerous high-incidence cancer types. These treatment recommendations can be a...

2020-09-03 08:45 3328

Guide IR Fever Warning Systems Help Canadian Schools Fight against COVID-19

CALGARY, Canada, Sept. 2, 2020 /PRNewswire/ -- Guide Sensmart ("the Company"), a world leading manufacturer of infrared thermal imaging systems has supplied its mass fever screening solutions to schools in Canada in the fight against the COVID-19 pandemic as students are returning to school. Gui...

2020-09-03 00:59 1873

Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels

COTIGNOLA, Italy, Sept. 3, 2020 /PRNewswire/ -- Concept Medical Inc ., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the TRANSFORM-1

2020-09-03 00:55 3842

George Clinical Adds CRO Business Development and Operations Veteran to Lead Efforts in China

OVERLAND PARK, Kansas, Sept. 3, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has expanded the organization's team inChina with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations.  Zhenfei will...

2020-09-03 00:00 3235

NIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test

The U.S. company's molecular test simultaneously identifies presence of influenza types A and B CHARLOTTESVILLE, Virginia, Sept. 3, 2020 /PRNewswire/ -- MicroGEM today announced it has been awarded up to$40.9 million by the National Institutes of Health (NIH), Rapid Acceleration of Diagnostics (...

2020-09-02 23:05 1993

PharmAbcine is presenting at the KSMO 2020

DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotechnology company in South Korea, announced today that onSeptember 4th, the company will present the interim data of its ongoing IO combo clinical trials at KSMO 2020. KSMO 2020 is the...

2020-09-02 21:00 1915
1 ... 630631632633634635636 ... 807